Previous studies have otherwise shown that the ceramide synthase inhibitor FTY720 [48] prevented diabetes development in NOD mice [49], highlighting the diverse roles of different sphingolipids in diabetes pathology. The gene discussed is TLCD3B; the disease is diabetes mellitus.